HealthQuill Articles by: HealthQuill
Pfizer’s investigations on gene therapy for patients with Duchenne muscular dystrophy failed to meet its primary goals, according to a company statement.
Drugs Health Pharma

Pfizer’s Duchenne muscular dystrophy trial fails to meet primary goal

Pfizer’s investigations on gene therapy for patients with Duchenne muscular dystrophy failed to meet its primary goals, according to a company statement.

Read More
The US drug regulator has granted accelerated approval for a drug to treat chronic inflammatory liver disease to Genfit, headquartered in Nord, France, and Paris-based Ipsen, according to the companies.
Drugs Health Pharma

FDA gives approval for Ispen, Genfit’s drug to treat chronic liver disease

The US drug regulator has granted accelerated approval for a drug to treat chronic inflammatory liver disease to Genfit, headquartered in Nord, France,

Read More
Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus vaccine from CSL Sequris UK Ltd., over a maximum period of four years to prevent the spread or potential outbreaks of bird flu in the region.
Drugs Health Pharma

EU to procure 40 million doses of avian flu vaccine from CSL Seqirus 

Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus

Read More
A four-year-old child in India has been detected with avian influenza A(H9N2) in the Eastern state of West Bengal, the World Health Organization reported.
Drugs Health Pharma

Child in India detected with bird flu in eastern West Bengal state: WHO 

A four-year-old child in India has been detected with avian influenza A(H9N2) in the Eastern state of West Bengal, the World Health Organization

Read More
A 59-year-old person in Mexico died in April after contracting avian influenza A(H5N2) virus, the first such death in the country, according to the World Health Organization.
Drugs Health Pharma

Person in Mexico dies after contracting avian influenza, WHO says

A 59-year-old person in Mexico died in April after contracting avian influenza A(H5N2) virus, the first such death in the country, according to

Read More
The advisory committee of the US Food and Drug Administration has rejected a therapy using party drug MDMA, or ecstasy or molly to treat post-traumatic stress disorder.
Drugs Health Pharma

FDA advisers reject psychedelic party drug MDMA to treat PSTD in adults

The advisory committee of the US Food and Drug Administration has rejected a therapy using party drug MDMA, or ecstasy or molly to

Read More
AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.
Drugs Health Pharma

AstraZeneca completes $2.4 billion acquisition of Fusion Pharma

AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.

Read More
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or melanoma.
Drugs Health Pharma

Moderna, Merck’s skin cancer vaccine shows rise in survival rates

Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or

Read More
Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer responds to immunotherapy drugs.
Drugs Health Pharma

NIH researchers make AI tool to read cancer responses to immunotherapy

Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer

Read More
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.
Drugs Health Pharma

GSK’s blood cancer test drug halves risk of disease progression: Data 

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a

Read More